NFKB1 and non-small cell lung carcinoma: To identify candidate of radiosensitizers that inhibit IR-induced NF-κB activation in NSCLC cells, the 83 selected compounds were prepared and primary screening for candidates that regulated the transcriptional activity of NF-κB in IR irradiated cells was performed using a reporter gene assay.